Suppr超能文献

Ferrara 角膜内环段行角膜交联术治疗进展性圆锥角膜的即刻疗效、角膜地形图及视觉效果

Refractive, topographic, and visual outcomes of same-day corneal cross-linking with Ferrara intracorneal ring segments in patients with progressive keratoconus.

机构信息

Department of Ophthalmology, Erasmus MC, Rotterdam, the Netherlands.

出版信息

Cornea. 2011 Dec;30(12):1406-8. doi: 10.1097/ICO.0b013e3182151ffc.

Abstract

PURPOSE

To report refractive, topographic, and visual outcomes 12 months after same-day treatment with corneal cross-linking (CXL) and Ferrara intracorneal ring segments (ICRS) in eyes with progressive keratoconus (KC) and contact lens intolerance.

METHODS

This was a case series of 7 eyes (7 patients) with progressive mild to moderate keratoconus and contact lens intolerance undergoing implantation of Ferrara ICRS immediately followed by corneal cross-linking. Uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), refractive error, pachymetry, and keratometry were evaluated at 3, 6, and 12 months of follow-up.

RESULTS

Mean follow-up was 11.7 ± 3.6 months (range, 5-17 months). Mean preoperative UCVA and BSCVA were 0.10 ± 0.07 (range, 0.05-0.2) and 0.56 ± 0.08 (range, 0.5-0.7), respectively. One year after the treatment, mean UCVA and BSCVA measured 0.60 ± 0.24 (range, 0.32-0.9) and 0.82 ± 0.25 (range, 0.5-1.2), respectively. The mean spherical equivalent decreased significantly (P < 0.05) with 3.5 diopters (D). Mean K values (average keratometry of the cornea) decreased from 46.81 ± 2.13 D (range, 44-51 D) to 43.97 ± 2.22 D (range, 42-47.5 D) 1 year after the treatment. The average preoperative thinnest pachymetry measured 462 ± 46 μm (range, 410 ± 546 μm) and did not change significantly after the treatment. In patient 1, the inferior ICRS was removed 5 months postoperatively because of implant migration.

CONCLUSIONS

The combined treatment of corneal cross-linking and Ferrara ICRS is a safe procedure that may be considered in patients with progressive mild to moderate KC and contact lens intolerance.

摘要

目的

报告角膜交联(CXL)和 Ferrara 角膜内环段(ICRS)同日治疗后 12 个月的屈光、地形和视觉结果,这些患者患有进展性圆锥角膜(KC)和接触镜不耐受。

方法

这是一项对 7 只眼(7 例患者)的病例系列研究,这些眼患有进展性轻度至中度圆锥角膜和接触镜不耐受,行 Ferrara ICRS 植入后立即行角膜交联。在随访的 3、6 和 12 个月时评估未矫正视力(UCVA)、最佳矫正视力(BSCVA)、屈光不正、角膜厚度和角膜曲率。

结果

平均随访时间为 11.7 ± 3.6 个月(范围,5-17 个月)。平均术前 UCVA 和 BSCVA 分别为 0.10 ± 0.07(范围,0.05-0.2)和 0.56 ± 0.08(范围,0.5-0.7)。治疗 1 年后,平均 UCVA 和 BSCVA 分别为 0.60 ± 0.24(范围,0.32-0.9)和 0.82 ± 0.25(范围,0.5-1.2)。平均等效球镜显著降低(P < 0.05),降低了 3.5 屈光度(D)。平均 K 值(角膜平均角膜曲率)从治疗前的 46.81 ± 2.13 D(范围,44-51 D)下降到 1 年后的 43.97 ± 2.22 D(范围,42-47.5 D)。治疗前平均最薄角膜厚度为 462 ± 46 μm(范围,410 ± 546 μm),治疗后无明显变化。在 1 例患者中,术后 5 个月因植入物移位而取出下象限的 ICRS。

结论

角膜交联和 Ferrara ICRS 的联合治疗是一种安全的治疗方法,可考虑用于进展性轻度至中度 KC 和接触镜不耐受的患者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验